1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine, 95%, 1g

5-Chloro-2-methylquinoline, 95.0%, 250mg

Z-Cys(pMeOBzl)-OH, = 98% (HPLC), 5g

2-(pyrrolidin-1-yl)propan-1-amine; oxalic acid, 95.0%, 2.5g

Boc-(�)-trans-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid, 98.0%, 1g

2-Chloro-n-(2,3-dimethyl-5-sulfamoylphenyl)acetamide, 97%, 100mg

Fosfato dihidrógeno de sodio monohidrato, mínimo 98 %, pa, ACS, 25 kg, envase de plástico.

[2-(1H-pyrazol-1-yl)ethyl]amine dihydrochloride, 95.0%, 1g

Methyl 4-phenylbutanoate, 95.0%, 5g

(S)-2-(p-tolyl)pyrrolidine, 95.0%, 1g

Triphenylethoxysilane, 95%, 1g

2-(3-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Bi polvo 99,99+% -200 malla 250 g